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Abstract
We developed robust, ultrasensitive, and accurate quantitative assays for maedi-visna virus (MVV) RNA and DNA genomic sequences
and mRNA’s expressed at various stages of lentiviral replication. Assay design was based on PCR with real-time fluorescence resonance
energy transfer measurements. Specific assays were developed for gag-pol (genomic), tat, rev, env, and vif transcripts. Assay linearity ranged
from 60 to 6  107 copies of target DNA. All assays were able to detect and measure corresponding mRNA’s in MVV-infected FOS cells,
whereas no signal was detected in mock-treated cells. In addition, RT-PCR based on amplification of gag sequences could be used to
quantify RNA genomic sequences in supernatants from infected cells. These quantitative assays can be used to study the role of genetic
elements in MVV infection and pathogenesis. They also allow rapid testing of lentiviral vectors and packaging systems based on MVV.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The replication cycle of lentiviruses, a subfamily of ret-
roviruses, consists of defined steps requiring several cis and
trans genetic elements. Lentiviral genomes include three
open reading frames (ORFs), gag, pol, and env, common to
all retroviruses. In addition, they contain several accessory
genes mostly implicated in regulation of viral gene expres-
sion. Maedi-visna virus (MVV) is a lentivirus that infects
sheep resulting in chronic progressive pulmonary disease
(maedi) and degenerate CNS affection (visna) (Sigurdsson
et al., 1957; Petursson et al., 1991). MVV contains ORFs for
transcriptional transactivator (tat), regulator of viral protein
expression (rev), and vif of poorly characterized function.
Cells infected by MVV contain several different tran-
scripts. A full-length genomic transcript (9.4 kb) also serves
as mRNA for gag and pol. The major splice donor of MVV
has the consensus sequence AAG/GTAAGA, and the splice
junction is between nucleotides 304 and 305 of the viral
RNA (Sonigo et al., 1985; GenBank Accession No.
470313). Three spliced transcripts of 5.0 kb for vif and 4.3
and 3.7 kb that contain the whole env ORF and two small
multiply spliced transcripts of 1.8 and 1.5 kb for tat and rev
are present in MVV-infected cells (Davis et al., 1987; Vigne
et al., 1987). In the early phase of lentiviral infection, small
multispliced mRNA’s for regulatory proteins are expressed,
followed by expression of larger mRNA’s (Vigne et al.,
1987).
To facilitate characterization of function of MVV cis and
trans genetic elements in vitro in cell culture and in vivo in
the animal, we have developed robust, ultrasensitive, and
accurate quantitative assays for specific DNA and RNA
molecules present at various stages of viral replication.
Assay design was based on PCR with real-time fluorescence
resonance energy transfer (FRET) measurements. Assays
were designed with two fluorochrome-labeled probes that
hybridize adjacent to each other on target DNA (Fig. 1)
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(Wittwer et al., 1997a). One hybridization probe is labeled
with a donor fluorophore, fluorescein. Excitation of the
donor fluorochrome with light of correct wavelength causes
FRET to the Cy5 acceptor fluorochrome on the adjacent
probe. This results in measurable light emission of a longer
wavelength, which correlates closely with amount of tem-
plate available for probe binding. FRET is only effective
over very short distances (10 nm). Free probes in solution
generate essentially no signal nor do probes spaced more
than a few nucleotides apart on a template (Glazer and
Mathies, 1997).
Assay specificity for the various mRNA’s expressed by
MVV is achieved by using carefully selected primer-bind-
ing sites and probes resulting in FRET between donor and
recipient fluorescent probes straddled across splice sites.
The combination of PCR amplification coupled with real-
time FRET measurement creates ultrasensitive assays capa-
ble of detecting less than zeptomolar (1021 M) amounts
of nucleic acid sequences.
Results
Several primers were designed to create (RT)-PCR-
FRET assays for MVV genomic RNA, proviral DNA, and
various mRNA’s. Assay specificity was achieved by using
two strategies: (1) binding sites for PCR primers were
carefully selected so that amplification would only occur if
message was spliced, because unspliced RNA would be too
long for efficient amplification. In addition, binding sites for
certain primers were only retained in some mRNA’s but not
others. (2) Binding sites for FRET probes were on each side
of spliced introns. With this arrangement, FRET would only
occur in correctly spliced transcripts. Based on this strategy
we were able to select appropriate sets of amplification
primers and FRET probes to design assays to measure
specific transcripts (Table 1 and Fig. 2).
An assay for quantitative analysis of MVV DNA was
developed using plasmid p8XSp5 as standard. This plasmid
includes the 5 sequence of clone KV1772-kv72/67, as
previously described (Skraban et al., 1999). Amplification
primers and FRET probes for gag sequences were designed,
to amplify genomic RNA but not mRNA’s spliced by the
major 5 splice donor (Table 1). PCR-FRET resulted in a
linear range when between 60 and 60 million copies were
Fig. 1. Principle of fluorescence resonance energy transfer measurements.
One hybridization probe is labeled with donor fluorochrome fluorescein
(F). Excitation of the donor fluorochrome with light of correct wavelength
results in FRET to Cy5 acceptor fluorochrome (Cy5) on adjacent probe.
The emitted light signal from excited Cy5 correlates closely with amount
of template available for probe binding because FRET is only effective
over very short distances (10 nm) between cohybridized probes.
P, 3 phosphate group, which prevents elongation from the acceptor probe
during amplification.
Table 1
Oligonucleotides used in this study
Name Sequence 5–3 mRNA Genomic localizationa
A. Primers
Gag-877F AGC AAC TCT ACC CCA ACT TA gag/pol 877–896
Gag-1092R GCT CTA TTC CCA GGC ATC AT gag/pol 1111–1092
Vif-235F TGA GGA CGG CGA GGA GAG TAA C vif 235–256
Vif-431R TCT TTT GGT GGC GGT ATG AAC TTA vif 4992–4969
v-208F GTT ACG GGA CCA CGG ACG CTG CTC rev, env 208–231
Env-441R CCA GTC CCT GCT GTT CTT CTT CC env 6091–6069
Env2-456R TTG TAG TCT TTC GCC AGG T tat, env 5779–5761
Env2-856R CAC CTG TGC AAA CCA CTT TTC AC env 6201–6179
Rev-484R TGC TTC TAT CAC CAC TGT TAC CTG rev 8586–8563
Tat-406F TGG GAA TGT TGG GAC TAT GTA AGT C tat 5729–5753
Tat-824R TCC ACC GGT GCT TCT ATC A tat 8594–8576
B. Probes
Gag-Flu CAA ACA GTG GCA ATG CAG CAT GG-Fb gag/pol 987–1009
Gag-Cy5 Cy5-CTT GTG TCC GAG GAT TTT GAG AG-P gag/pol 1011–1033
SA1 CCT GGA TGC CCT CTT TTT CTT GT-F rev, env, vif 4854–4876
SA2 TTT CTT TGC TGG CCA TCC TAG AC-F rev, env 5950–5976
SA3 GAT GGA TTC CAT TTC CCA GCA TT-F tat, env 5626–5648
Major-SD Cy5-CTT ACT TCA GGC GTC CCC GAA GC-P rev, env, vif 282–304
Tat-753-Flu GAA GAA CAG CAG GGA CTG GTA TC-F tat 6073–6095
Tat-779-Cy5 Cy5-CTT ACA AGC AAG TAA AGC AGA TC-P tat 8531–8553
a Genomic localization in molecular clone KV1772-kv72/67 (Andresson et al., 1993; GenBank Accession No. 265825).
b Abbreviations of modifications of molecular probes: Cy5, Cy5 dye; F, fluorescein; P, 3 phosphate.
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included per reaction (6 orders of magnitude). The results
from these were used for construction of a standard curve
(Fig. 3). Intraassay coefficient of variation (CV) for the
assay was 12% and interassay CV was 17%. Efficiency of
amplification was 1.88/cycle. To demonstrate the use of
this assay for quantification of RNA genomic sequences,
RT-PCR based on amplification of gag sequences was car-
ried out in supernatants from infected cells. We measured
Fig. 2. Location of primers and probes on MVV transcripts. Genome structure of MVV provirus is illustrated on top of diagram for reference. Primers and
probes are represented by arrows and short lines, respectively. Their sequences and positions are listed in Table 1. Dashed lines indicate splicing. Numbers
in parentheses indicate position in spliced transcripts. SD, splice donor; SA, splice acceptor. Small env transcripts use SA 5946 and large env transcripts use
SA 5625. Nucleotide sequence numbers are based on MVV clone KV1772-kv72/67 (Andresson et al., 1993; GenBank Accession No. 265825).
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3  104 molecules/l MVV genomic RNA in supernatant,
whereas no signal was generated in mock-transfected con-
trol cells.
For the quantification of the vif transcript, primers Vif-
235F and Vif-431R were used (Fig. 2). The forward primer
was situated 5 of the major splice donor. The reverse
primer was located 3 of start codon of the vif ORF and in
a region spliced out of other MVV mRNA’s. Amplification
from infected fetal ovine synovial (FOS) cells resulted in a
product of 219 bp (Fig. 4A), which was cloned in PCR-
Script plasmid and sequenced. The sequencing revealed that
the splice acceptor site at 4843 was used for the vif tran-
script, confirming previsously described results (Vigne et
al., 1987). The assay could quantify 60 to 60 million copies
of target DNA (Fig. 5). The intraassay CV for the vif assay
was 13% and interassay CV was 15%. Efficiency of ampli-
fication was 1.91/cycle. When electrophoresis of PCR
products on agarose gels (Fig. 4A) is compared to results
from the real-time FRET measurements (Fig. 5), the advan-
tage of using the latter method for quantification is shown.
A difference in quantity between the highest standards
(60,000 to 60 million molecules/l) could not be detected
on agarose gel, and a product in the reaction using the
Fig. 4. PCR products created by reverse transcription and amplification of
MVV mRNA’s from KV1772-kv72/67-infected FOS cells. For primers
and probes, see Table 1 and Fig. 2. Products (2 l) after 45 cycles of PCR
were electrophoresed in 1.7% agarose. Size marker was X174 DNA cut
with HaeIII. (A) Amplification with primers Vif-235F and Vif-431R for
the vif product (second lane from the right). Vif cDNA was cloned in
plasmid and used in a linearized form in lanes 2–9 to generate a standard
curve. End point analysis is very inferior to real-time PCR-FRET curves in
Fig. 5. (B) Amplification with primers v-208F and Env-441R for the small
env product. (C) Amplification with primers v-208F and Env2-456R for the
large env product. (D) Amplification with primers v-208F and Env2-859R
for the large env product. (E) Amplification with primers Tat-406F and
Tat-824R for the tat product. (F) Amplification with primers v-208F and
Rev-484R for the rev product.
Fig. 3. PCR-FRET amplification of gag-pol sequences from genomic DNA
template. The template was linearized plasmid p8XSp5, which contained
the 5 sequence of clone KV1772-kv72/67 including relevant gag-pol
region. For gag-pol primers and probes, see Table 1 and Fig. 2. (A)
Amplification curves based on real-time fluorescence measurements during
PCR. Assays were performed in duplicate on seven samples representing a
10-fold dilution series ranging from 60 to 60 million copies of template.
(B) Semilogarithmic transformation of amplification curves in A. (C)
Standard curve demonstrating a linear relationship between logarithm of
copy number of template versus PCR cycle number. PCR cycle number
was calculated from intersections of extrapolated straight lines between
two lowest points in each curve in B and background noise band. The
standard curve was linear over 6 orders of magnitude.
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lowest standard (60 molecules/l) could not be detected
(Fig. 4A).
For an assay to quantify the small (3.6 kb) env transcript,
primers v-208F and Env-441R were used to form PCR
products. The forward primer was positioned 5 of the major
splice donor at site 304. The reverse primer was located 3
of splice donor site at 6097 in a region absent from the tat
and rev transcripts (Fig. 2). PCR using these primers re-
sulted in amplification of two amplicons of 289 and 243 bp
(Fig. 4B). Both products were cloned into PCR-Script plas-
mid and sequenced. The two products resulted from differ-
ent splicing. The smaller fragment, cloned in construct
pENV-2ex, was a product of one splice event, where splice
acceptor at site 5946 was used. The larger fragment, cloned
in construct pENV-3ex, was the product of two splice
events and included a small fragment of the pol gene (4843–
4888). This fragment is also included in tat and rev tran-
scripts (Gourdou et al., 1989; Mazarin et al., 1988). The
second splice acceptor was at site 5946 as in the single-
spliced message (Fig. 2). Specific assays for both splice
variants were developed. Probe Major-SD was used with
probe SA1 for the three exon transcript and with probe SA2
for the two exon transcript (Fig. 2). Standard curves were
made and both assays allowed quantification of 60 to 60
million copies of target DNA. Intraassay CVs for the assays
for pENV-3ex and pENV-2ex were 6 and 14%, respec-
tively. Interassay CVs were 12% for pENV-3ex and 17%
for pENV-2ex. Efficiency of amplification for the pENV-
3ex assay was 1.92/cycle, and for the pENV-2ex assay,
1.97/cycle.
The cloning of a PCR product representative of the larger
(3.9 kb) env mRNA was carried out using primer v-208F as
forward primer coupled with either reverse primer Env2-
456R or reverse primer Env2-856R (Table 1 and Fig. 2).
Using reverse primer Env2-456R with v-208F also resulted
in amplification of the multiply spliced tat mRNA, which
utilizes the splice site at 5625 (Fig. 2). PCR using these
primers created products of 251 and 297 bp (Fig. 4C), which
were cloned in pBluescript to construct plasmids pET-2ex
and pET-3ex, respectively. Sequencing of the plasmid in-
serts revealed that their size difference resulted from differ-
ential splicing of the small fragment from the pol gene
discussed above. The second splice event occurred with site
5625 as splice acceptor (Fig. 2). Probes for fluorescence
detection were selected across the different splice junction
sites. Probes Major-SD and SA3 were used for the two exon
transcript (pET-2ex), and probes Major-SD and SA1, for the
three exon transcript (pET-3ex) (Fig. 2). Standard curves
were made and both assays were linear over the range of 60
to 60 million copies of target DNA. Intraassay and interas-
say CVs for pET-3ex were 16 and 12%, respectively. In-
traassay and interassay CVs for pET-2ex were 9 and 14%,
respectively. Efficiency of amplification for the two assays
was 1.98/cycle for pET-3ex and 1.96/cycle for pET-
2ex. With the pET-3ex and pET-2ex assays we were unable
to distinguish between the tat transcript and the large env
transcript.
Using forward primer v-208F coupled with reverse
primer Env2-856R (Fig. 2) resulted in amplification of sev-
eral PCR products in various amounts (Fig. 4D). Primer
Env2-856R has the advantage of being complementary to a
sequence absent from tat and rev transcripts. The two
smaller bands (352 and 397 bp) were the results of ampli-
fication of the smaller env mRNA, but two larger fragments
were from the amplification of the larger env transcript,
resulting in PCR products of 673 and 718 bp. The larger
PCR products were cloned into pBluescript, to construct
pENVL-2ex and pENVL-3ex, respectively. The fragments
were sequenced, the size difference being the result of
splicing of the pol fragment into the larger splice variant.
Quantitative assays for these transcripts were developed
using fluorescent probes Major-SD and SA3, for the two-
exon transcript, and Major-SD and SA1, for the three-exon
transcript. Both assays were linear over the range of 600 to
60 million copies of target DNA. The intraassay CV for
Fig. 5. Real-time PCR-FRET monitoring of vif cDNA amplicons shown in
Fig. 4A. For explanation of graphs in A–C, see the legend to Fig. 3. The
light brown curve (marked with an asterisk in A and B) represents cDNA
amplification from FOS cells infected with KV1772-kv72/67. Other curves
represent amplifications from 60 to 60 million copies of cloned template as
standard. Curves from mock-treated cells and samples with 6 copies of
standard did not rise above background.
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pENVL-3ex was 16%, the interassay CV was 14%, and
efficiency of amplification for the assay was 1.69/cycle.
The intraassay CV for pENVL-2ex was 20%, the interassay
CV was 13%, and efficiency of amplification was
1.73/cycle. Even though amplification with primers
v-208F and Env2-856R generated both large and small env
transcripts, the assay was made specific for large env
mRNA’s by using probes Major-SD and SA3 (Fig. 2).
There would, however, be fluorescence detection of the
small env mRNA from cells if the SA1 probe were used.
The PCR product using primers Tat-406F and Tat-824R
representative for the tat mRNA (Table 1 and Fig. 2) re-
sulted in amplification of 434-bp cDNA from KV1772-
kv72/67 infected FOS cells (Fig. 4E). The forward primer
was located 5 of SA 5946, used in generating rev tran-
scripts. This design distinguishes tat mRNA from the
mRNA of rev (Fig. 2). The reverse primer was located 3 of
SA 8530, making formation of large PCR products from
genomic RNA, or vif and env mRNA’s, improbable because
of their length. The 434-bp fragment was cloned into TA-
cloning vector. Sequencing of a plasmid clone (pTAT)
showed the sequence of the tat cDNA to be identical to the
previously described sequence of tat mRNA (Gourdou et
al., 1989). Probes for fluorescence detection, Tat-753-Flu
and Tat-779-Cy5, were selected across the third splice junc-
tion of the transcript. This design resulted in an assay
specific for the tat transcript. The tat assay was linear over
the range of 60 to 60 million copies. Intraassay CV was 14%
and interassay CV was 18%. Efficiency of amplification for
the tat assay was 1.96/cycle.
For the cloning of a PCR product for the rev transcript,
primers v-208F and Rev-484R were used. The forward
primer was positioned 5 of the major splice donor and the
reverse primer was 3 to the splice acceptor site 8530 (Fig.
2). Amplification with these primers on MVV cDNA re-
sulted in three amplicons, of 350, 305, and 154 bp (Fig. 4F).
A possible tat transcript amplification of 672 bp from FOS
cytoplasm was not detected. All three PCR products were
cloned and the inserts were sequenced. The smallest frag-
ment represented two exons (pREV-2ex) resulting from a
splicing event between the major splice donor 304 and
splice acceptor 8530. The middle fragment contained three
exons (pREV-3ex) with the first splice acceptor 5946 and
the latter splice event between splice donor 6097 and splice
acceptor 8530. The large fragment (pREV-4ex) had four
exons, created by three splicing events, as previously de-
scribed (Mazarin et al., 1988). An assay for the multiply
spliced transcript was developed for pREV-4ex and pREV-
3ex. Probes Major-SD and SA1 were used for the four-exon
transcript, and probes Major-SD and SA2, for the three-
exon transcript (Fig. 2). A linear range from 60 to 60 million
copies of target DNA was noted with both assays. Intraassay
CV was 10% for the pREV-3ex assay and 18% for the
pREV-4ex assay and the interassay CVs were 9 and 18%,
respectively. Efficiency of amplification was 1.87/cycle
for both assays.
We determined if the assays could measure level of
transcripts in cell culture. FOS cells were transfected with
cloned replication-competent MVV in plasmid LV1-1KS2
or infected with molecular clone KV1772-kv72/67. Cells
were harvested and cytoplasm was collected at various
stages posttransfection or postinfection. Assays for all dif-
ferent MVV RNAs measured the specific transcripts in
various amounts in all tested samples. Levels of all tran-
scripts were within the linear range of the corresponding
assay and considerably higher than the lowest standards.
Levels were generally from 102 to 1.5  104 molecules/l
for different mRNA’s. In contrast, no signals for any of the
assays were generated in mock-transfected controls, dem-
onstrating their specificity.
Discussion
We have designed primers and probes for quantitative
assays to measure MVV RNA genome and DNA provi-
ruses as well as transcripts for gag-pol, vif, tat, env, and
rev. We defined PCR conditions for efficient amplifica-
tion and quantification of these nucleic acid sequences
using real-time fluorescence measurement. Design of as-
says allows specific measurements of individual tran-
scripts. PCR-FRET resulted in high sensitivity with the
capability of quantifying nucleic acid templates to as few
as 60 copies per reaction. Only the assay for the larger
env mRNA had higher detection limits, 600 copies per
reaction, presumably because of the length of the ampli-
con. This amount is much lower (often orders of magni-
tude) than levels of transcripts present in most infected
cell culture preparations. Assay sensitivity facilitates
measurement of MVV genetic elements in biologic ma-
terial available in very limited quantity or where MVV is
present at low levels. Because assays were linear over 6
orders of magnitude, analytic levels should very rarely be
outside of the measurement range. The assays are robust,
reagents are relatively cheap, and labor is modest. The
assays do, however, rely on a highly specialized equip-
ment, the LightCycler instrument. In this thermocycler,
PCR analysis is carried out in capillary glass reaction
cuvettes allowing rapid heat exchange. This results in
small intrasample temperature variation despite fast (i.e.,
30 min) 45-cycle PCR assays. This is optimal design for
analytical work based on real-time fluorescence detec-
tion. There is no reason, however, why these assays could
not be modified for use in other PCR instruments with
real-time fluorescence capability. The same primers and
probes could be used because the fluorochromes used
require excitation and emission wavelengths commonly
available on such instruments. Conditions for PCR
would, however, need to be optimized for each type of
instrument. If genetic variation coincides with primer- or
probe-binding sites, adjustment in their sequences should
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be straightforward. Similar quantitative assays could also
be developed for other lentiviruses.
The MVV mRNA’s have very similar 5 and 3 ends, and
the problem of contamination of an assay by amplification
of other mRNA’s was a concern, for example, would-be
formation of a 672-bp tat transcript when using primers for
the rev assays. However, this transcript apparently could not
compete with shorter transcripts in RT-PCR analysis, per-
haps in part because of the short duration of the elongation
step in PCR analysis (12 s).
The quantitative assays described in this work can be
used to study the role of genetic elements in MVV infection
and pathogenesis. They also allow rapid testing of lentiviral
vectors and packaging systems based on MVV. The assays
could also be further developed and investigated as diag-
nostic tests for MVV infection, including assessing virus
load and stage of infection.
Materials and methods
Primers and probes
PCR primers and FRET hybridization probes for MVV
RNA of molecular clone KV1772-kv72/67 (Andresson et
al., 1993; GenBank Accession No. 265825) were designed
by using Oligo (National Biosciences, Inc., Plymouth, MN)
and MacVector (Oxford Molecular Group, Oxford, UK)
computer programs. Sequences of PCR primers and hybrid-
ization probes are shown in Table 1. A schematic localiza-
tion of oligonucleotides in the MVV genome and mRNA’s
is shown in Fig. 2.
Infection and transfection of FOS cells
FOS cells were grown at 37°C in humidified atmosphere
of 5% CO2 in Dulbecco’s minimal essential medium
(DMEM) (GibcoBRL Life Technologies, Paisley, UK) sup-
plemented with 2 mM glutamine, 100 IU/ml penicillin, 100
IU/ml streptomycin, and either 10% lamb serum (growth
medium) or 1% lamb serum (maintenance medium). Sub-
confluent monolayers of FOS cells were infected with su-
pernatant from sheep macrophages infected with molecular
clone KV1772-kv72/67 (Andresson et al., 1993) using stan-
dard techniques (Ausubel et al., 1994). Cells were harvested
for RNA isolation 48, 72, and 96 h postinfection. Viral
transcripts from infected FOS cells were used for cloning of
PCR products by RT-PCR.
To generate mRNA for quantification, 5 g of molecular
clone LV1-1KS2 (Staskus et al., 1991) was transfected in
FOS cells using calcium phosphate coprecipitation method
(Graham and van der Eb, 1973). Transfected cells were
incubated in DMEM with 10% newborn calf serum for 48 h.
In all experiments mock-treated cells (transfected without
plasmid) were used as negative controls.
RNA isolation
Total RNA was isolated from cytoplasm of infected FOS
cells using RNA isolation kit (Stratagene, La Jolla, CA).
The manufacturer’s instructions were scaled down 20 times.
Viral particles from supernatant culture fluid were concen-
trated with ultracentrifugation in Beckman L5-50E at
50,000 g for 90 min and resuspended in 140 l phosphate-
buffered saline. Viral RNA was isolated from supernatant
using QIAamp viral RNA mini kit (QIAgen, Venlo, the
Netherlands) according to the manufacturer’s instructions.
To eliminate DNA contamination, RNA samples were
treated with 1 l DNase (2 U/l; Ambion, Austin, TX) in
10 transcription buffer (Ambion) for 20 min at 37°C and
15 min at 70°C.
Reverse transcriptase reaction
cDNA was constructed using the Thermoscript RT-PCR
system (Life Technologies) according to the manufacturer’s
instructions. Random hexamers (50 ng/l) were used to
prime reverse transcriptase. The reaction samples were in-
cubated at 25°C for 10 min, 50°C for 50 min, and 85°C for
5 min.
PCR-FRET
PCR was carried out in a LightCycler (Idaho Technol-
ogy, Idaho Falls, ID) (Wittwer et al., 1997b) using linear-
ized plasmids as templates. Reaction samples (10 l) con-
tained 200 M each dNTP, 0.5 M primers, 0.2 M
fluorescent probes, 0.08 U/l KlenTaq1 polymerase (Ab
Peptides, Inc., St. Louis, MO) diluted in enzyme diluent
buffer (10 mM Tris, pH 8.3, 250 g/ml BSA; Idaho Tech-
nology), and reaction buffer (50 mM Tris, pH 8.3, 4 mM
MgCl2, 250 g/ml BSA; Idaho Technology). Mixing and
dilutions were carried out in Eppendorf tubes lubricated
with silicon. All assays were performed in duplicate. PCR
products were characterized by electrophoresis on 1.7%
agarose gels, using X174 (250 ng) cut with HaeIII as size
marker.
Temperature profiles of PCR assays consisted of initial
denaturation step for 2 min at 94°C, followed by 45 cycles
of denaturation for 0 s at 94°C, annealing with fluorescence
monitoring for 0 s at 58°C, and elongation at 72°C. Elon-
gation time was set depending on PCR product length: 10 s
for the gag, vif, pET-2ex, pENV-2ex, and pENV-3ex as-
says; 12 s for the tat, pREV-3ex, pREV-4ex, and pET-3ex
assays; and 22 s for the pENVL-2ex and pENVL-3ex as-
says.
Calculations of amplification efficiency and coefficients of
variation
Efficiency of amplification was calculated based on dif-
ferences in the number of cycles (n and m) when amplified
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DNA in two PCR assays with different amounts of original
template (D is the ratio of difference) reached same baseline
level above limit of detection. With these parameters, effi-
ciency of amplification X (max. 2) was calculated as the
common ratio from geometric series using the following
formula: X  10logD/nm. CVs were calculated based on
differences between duplicate assays. Mean CVs were
based on analysis of at least seven duplicates.
Cloning and manipulation
PCR products were cloned with TA-cloning vector
pCR2.1 (Invitrogen, Groningen, The Netherlands) for tat
and the three-exon rev PCR products. Other PCR products
were cloned using PCR-Script Amp cloning kit (Strat-
agene). Both kits were used according to the manufacturers’
instructions. The PCR product representing the larger (4.3
kb) env mRNA generated with primers containing XbaI
heels (Table 1) was cloned in XbaI-digested pBluescript.
Plasmids were transformed and grown in Escherichia coli
strain DH5-F’IQ (Life Technologies).
Inserts in plasmid clones (400 ng) were sequenced with
ABI Prism BigDye terminator cycle sequencing ready re-
action kit (PE Biosystems, Foster City, CA) on ABI Prism
377 DNA sequencer. Sequencing was carried out using
primers T7, either primer T3 for inserts in PCR-Script Amp
cloning, or primer Met for inserts in TA-cloning vector.
Plasmids were digested with a restriction enzyme cutting
at a single site outside of intended PCR region. Following
linearization of plasmids and purification with GFX PCR
DNA and gel band purification kit (Amersham Biosciences
Inc., Piscataway, NJ) the DNA concentration was deter-
mined with Hoefer DyNA Quant 200 fluorometer (Amer-
sham Biosciences Inc., Piscataway, NJ), and the corre-
sponding copy number was calculated. Serial dilutions from
60 million to 60 copies of plasmids per microliter were done
in TLE (10 mM Tris, pH 8.0, 0.1 M EDTA) in tubes
lubricated with silicon.
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